Kim M, Han H
BMC Vet Res. 2023; 19(1):61.
PMID: 36932415
PMC: 10022049.
DOI: 10.1186/s12917-023-03614-3.
Opheim E, Apelseth T, Stanworth S, Eide G, Hervig T
Blood Transfus. 2019; 17(3):181-190.
PMID: 30747706
PMC: 6596372.
DOI: 10.2450/2018.0140-18.
Ddungu H, Krantz E, Kajja I, Naluzze S, Nabbanja H, Nalubwama F
PLoS One. 2019; 14(2):e0211648.
PMID: 30726290
PMC: 6364911.
DOI: 10.1371/journal.pone.0211648.
Oh H, Park J, Yoon S, Lee H, Lim C, Kim J
Dig Dis Sci. 2016; 62(3):746-754.
PMID: 28035550
DOI: 10.1007/s10620-016-4427-4.
Tay J, Allan D, Beattie S, Bredeson C, Fergusson D, Maze D
BMJ Open. 2016; 6(10):e013483.
PMID: 27798034
PMC: 5093651.
DOI: 10.1136/bmjopen-2016-013483.
Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party.
Tagariello G, Castaman G, Falanga A, Santoro R, Napolitano M, Storti S
Blood Transfus. 2016; 14(6):521-526.
PMID: 27416570
PMC: 5111376.
DOI: 10.2450/2016.0321-15.
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P
Cochrane Database Syst Rev. 2015; (10):CD010984.
PMID: 26505729
PMC: 4724938.
DOI: 10.1002/14651858.CD010984.pub2.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Crighton G, Estcourt L, Wood E, Trivella M, Doree C, Stanworth S
Cochrane Database Syst Rev. 2015; (9):CD010981.
PMID: 26422767
PMC: 4610062.
DOI: 10.1002/14651858.CD010981.pub2.
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy M
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722652
PMC: 4338578.
DOI: 10.1002/14651858.CD010984.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt L, Crighton G, Wood E, Stanworth S, Trivella M, Doree C
Cochrane Database Syst Rev. 2015; (3).
PMID: 25722649
PMC: 4338539.
DOI: 10.1002/14651858.CD010981.
Indications for platelet transfusion in patients with thrombocytopenia.
Squires J
Blood Transfus. 2014; 13(2):221-6.
PMID: 25369586
PMC: 4385069.
DOI: 10.2450/2014.0105-14.
How to further develop the evidence base for transfusion medicine.
Murphy M, Brunskill S, Estcourt L, Stanworth S, Doree C
Blood Transfus. 2012; 10(4):436-9.
PMID: 23117400
PMC: 3496221.
DOI: 10.2450/2012.0038-12.
Dose of prophylactic platelet transfusions and prevention of hemorrhage.
Slichter S, Kaufman R, Assmann S, McCullough J, Triulzi D, Strauss R
N Engl J Med. 2010; 362(7):600-13.
PMID: 20164484
PMC: 2951321.
DOI: 10.1056/NEJMoa0904084.
Recommendations for the transfusion of plasma and platelets.
Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G
Blood Transfus. 2009; 7(2):132-50.
PMID: 19503635
PMC: 2689068.
DOI: 10.2450/2009.0005-09.
